In silico design of angiotensin-converting enzyme 2 (ACE2) recombinant protein to block the S1 protein pathway of COVID-19 virus
<p>Coronavirus is a large family of viruses that includes the common cold and the SARS virus. The Chinese corona, or coronavirus, is a new respiratory virus that began in late 2019 and early 2020 in the province of Hubby and Wuhan, China, and became known as COVID-19. The COVID-19 virus genome...
Saved in:
Main Author: | Yaser Ghazi (Author) |
---|---|
Format: | Book |
Published: |
Open Journal of Proteomics and Genomics - Peertechz Publications,
2020-07-25.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015) -
Angiotensin converting enzyme 2 (ACE2) - the major receptor for SARS-CoV-2 virus
by: Sonia Frankowska, et al.
Published: (2021) -
Potential use of the S-protein-Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019
by: Long Feng, et al.
Published: (2022) -
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
by: Jingwei Bian, et al.
Published: (2021) -
Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies
by: Murtala Bello Abubakar, et al.
Published: (2021)